As of 2026-08-15, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -13.91 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 25.96 USD, the upside of Dyne Therapeutics Inc is -153.57%.
Based on its market price of 25.96 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 153.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.91 - -13.91 | -13.91 | -153.57% |
| P/E | (36.32) - (55.68) | (49.51) | -290.7% |
| DDM - Stable | (22.75) - (75.55) | (49.15) | -289.3% |
| DDM - Multi | (1.23) - (3.18) | (1.78) | -106.8% |
| Market Cap (mil) | 4,848.03 |
| Beta | 1.25 |
| Outstanding shares (mil) | 186.75 |
| Enterprise Value (mil) | 4,385.40 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.94% |
| Cost of Debt | 5.00% |
| WACC | 9.75% |